| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 04/04/2007 | CN1939303A Novel composition and use. |
| 04/04/2007 | CN1308302C Taxol enhancer compounds |
| 04/04/2007 | CN1307993C Macrolides-containing pharmaceutical compositions |
| 04/04/2007 | CN1307988C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199149 Monocyclic and bicyclic lactams as factor Xa inhibitors |
| 04/03/2007 | US7199143 3-[4-(3,6-dihydro-2H-thiopyran-4-yl) phenyl]-]5[1H or 2H-1,2,3-triazol-1 or 2-yl] oxazolidin-2-ones; grampositive bactericides for drug resistant bacteria, especially Staphylococcus, Enterococcus, and Streptococcus |
| 04/03/2007 | US7199134 Hydroxamic acid compounds and methods of use thereof |
| 04/03/2007 | US7199106 Lincomycin derivatives possessing antimicrobial activity |
| 04/03/2007 | US7199098 Copolymer-1 improvements in compositions of copolymers |
| 04/03/2007 | US7198652 Composition for dyeing keratinous fibers with a cationic direct dye and a quaternary ammonium salt |
| 04/03/2007 | CA2206782C Aerosol drug formulations |
| 04/03/2007 | CA2205275C Vitamin d3 analogs |
| 03/29/2007 | US20070072929 2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl 4-[(aminocarbonothioyl)amino]-4-oxobutanoate;potententiation; anaerobic/ aerobic microoraganisms; grampositive,gramnegative bacteria; Campylobacter; respiratory system disorders; paraciticides; nontoxic; enzymers/hydrolases/;enzyme inhibitors |
| 03/29/2007 | US20070072922 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
| 03/29/2007 | US20070072902 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 03/29/2007 | US20070072893 Substituted imidazo ring systems and methods |
| 03/29/2007 | US20070072874 Aminoheteroaryl compounds as protein kinase inhibitors |
| 03/29/2007 | US20070072872 Treating sexual desire disorders with flibanserin |
| 03/29/2007 | US20070072839 Leukemia Treatment Method and Composition |
| 03/29/2007 | US20070072835 Method of preparing and use of prodrugs of betulinic acid derivatives |
| 03/29/2007 | US20070072808 Antimicrobial and anticancer lipopeptides |
| 03/29/2007 | US20070072181 Combination therapy for treating alphavirus infection and liver fibrosis |
| 03/29/2007 | US20070071816 Oral drug delivery system |
| 03/29/2007 | US20070071812 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 03/29/2007 | US20070071775 Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination |
| 03/29/2007 | US20070071730 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 03/29/2007 | US20070071716 Compositions and methods for healthy pregnancy |
| 03/29/2007 | US20070071674 Polynucleotides encoding novel isoforms of IGSF9 |
| 03/29/2007 | US20070068959 Preparing for individualized dosage forms of medicaments |
| 03/28/2007 | EP1765400A2 Method for treating lupus |
| 03/28/2007 | CN1938040A Oxytocin controlled release formulations and methods of using same |
| 03/28/2007 | CN1935839A Analogues of glp-1 |
| 03/28/2007 | CN1935125A Pharmaceutical composition for modified release insulin sensitiser |
| 03/28/2007 | CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog |
| 03/28/2007 | CN1307177C Synthesis and purification of valacyclovir |
| 03/28/2007 | CN1307173C Pyrimidineamines as angiogenesis modulators |
| 03/27/2007 | US7196096 Substituted amines of spirofuropyridines useful in therapy |
| 03/27/2007 | US7196061 cyclic peptides and peptidomimetic used as agonists or antagonists of tyrosine kinase receptors; modulation of growth and repair of the central nervous system |
| 03/27/2007 | US7195790 Modification of cyclooxygenase and lipoxygenase activity with asteridae extracts and optionally boswellic acid |
| 03/27/2007 | US7195761 Humanized antibodies that sequester abeta peptide |
| 03/22/2007 | WO2006114474A3 Saline solution comprising [13n] nh4+ and a device |
| 03/22/2007 | WO2005058250A3 Methods of administering water-soluble prodrugs of propofol for extended sedation |
| 03/22/2007 | WO2005053615A3 Novel differential imaging method |
| 03/22/2007 | WO2005034862A3 Topical composition |
| 03/22/2007 | US20070066996 Modafinil-based neurorehabilitation of impaired neurological function associated with brian injury |
| 03/22/2007 | US20070066650 (R)-6-(2-(2,2,2-Trifluoroethyl)-1-pyrrolidinyl)-4-trifluoromethyl-2(1H)-quinolinone; partial agonist, agonist or antagonist of androgen receptor; cachexia and wasting diseases; male-pattern baldness; benign prostatic hyperplasia; hirsutism; acne |
| 03/22/2007 | US20070066639 Oxime substituted imidazoquinolines |
| 03/22/2007 | US20070066600 Compounds |
| 03/22/2007 | US20070066599 New compounds |
| 03/22/2007 | US20070066598 Compounds |
| 03/22/2007 | US20070066591 Compounds for treatment of cell proliferation disorder and prevention of kinesins |
| 03/22/2007 | US20070066570 Methods for treating sleep disorders |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/22/2007 | US20070066530 Methods for modulating gastric secretion using prokineticin receptor antagonists |
| 03/22/2007 | US20070066523 Chemokine analogs for the treatment of human diseases |
| 03/22/2007 | US20070065887 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/22/2007 | US20070065492 Cladribine formulations for improved oral and transmucosal delivery |
| 03/22/2007 | US20070065463 Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions |
| 03/22/2007 | US20070065438 Methods of inducing and maintaining immune tolerance |
| 03/22/2007 | US20070065433 Methods and compositions for the treatment of meconium aspiration syndrome |
| 03/22/2007 | US20070065364 Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same |
| 03/21/2007 | EP1616036A4 Method for identifying ligands specific for structural isoforms of proteins |
| 03/21/2007 | EP1144013B1 Lactone bearing absorbable polymers |
| 03/21/2007 | CN1934448A Method for the prevention of malaria |
| 03/21/2007 | CN1933822A Means for transdermal administration of nicotine |
| 03/21/2007 | CN1305524C Mycoplasma hyopneumoniae bacterin vaccine |
| 03/20/2007 | US7193230 Thin lightweight flexible cloth, tor treatment of garments with high molecular weight metal particles. |
| 03/20/2007 | US7192979 EP4 receptor selective agonist in the treatment of osteoporosis |
| 03/20/2007 | US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases |
| 03/20/2007 | US7192770 Screening for a test agent that increases or induces a component of the p21 signal transduction pathway, thereby reducing the appearance or formation of wrinkles; used in fragrance or sunscreen |
| 03/20/2007 | US7192718 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM) |
| 03/20/2007 | US7192613 Allium sativum bulb absolutes and therapeutic or cosmetic uses |
| 03/20/2007 | US7192596 Recombinant toxin fragments |
| 03/20/2007 | US7192595 Peptide-based vaccine for influenza |
| 03/20/2007 | US7192578 By administering antiinflammatory drugs |
| 03/20/2007 | CA2253517C Dual component dentifrice composition for dental fluoridation |
| 03/15/2007 | WO2005044186A3 Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same |
| 03/15/2007 | WO2005023202A3 Tumor suppressor lkb1 kinase directly activates amp-activated kinase |
| 03/15/2007 | WO2004103295A3 Interleukin-9 antagonist muteins and their pharmacological methods of use |
| 03/15/2007 | WO2004091499A3 Intracellular formation of peptide conjugates |
| 03/15/2007 | WO2004024073A3 Use of statins in the prevention and treatment of radiation injury and other disorders associated with reduced endothelial thrombomodulin |
| 03/15/2007 | US20070060754 Alkoxy substituted imidazoquinolines |
| 03/15/2007 | US20070060627 Organic compounds |
| 03/15/2007 | US20070060593 4-Carboxamido quinoline derivatives for use as nk-2 and nk-3 |
| 03/15/2007 | US20070060527 Orally administered small peptides synergize statin activity |
| 03/15/2007 | US20070059697 Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods |
| 03/15/2007 | US20070059454 Products for treating and preventing chronic diseases: eliminating the autoimmune triggers that underly chronic disease |
| 03/15/2007 | US20070059369 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 03/15/2007 | US20070059352 Therapeutic liposomes |
| 03/15/2007 | US20070059254 Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof |
| 03/14/2007 | EP1762567A1 Pyrazole derivatives for treating HIV |
| 03/14/2007 | EP1762236A2 Formulations of alpha adrenergic receptor antagonists and their uses |
| 03/14/2007 | EP1762145A1 Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom |
| 03/14/2007 | EP1694311A4 Chewable soft capsules containing ungelatinized starch |
| 03/14/2007 | EP1631279A4 Combination therapy for the treatment of neoplasms |
| 03/14/2007 | EP1227838B1 Melanoma vaccine and methods of making and using same |
| 03/14/2007 | CN1928224A Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom |
| 03/14/2007 | CN1928223A Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom |
| 03/14/2007 | CN1303996C use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders |